- Home
- CMPS vs EDD Comparison
CMPS vs EDD Comparison
Compare CMPS & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMPS | EDD |
|---|---|---|
| Founded | 2020 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 371.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMPS | EDD |
|---|---|---|
| Price | $13.25 | $5.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $25.38 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 308.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.88 | $4.96 |
| 52 Week High | $15.87 | $6.18 |
Technical Indicators
Market Signals| Indicator | CMPS | EDD |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 34.90 |
| Support Level | $12.95 | $5.42 |
| Resistance Level | $15.11 | $5.67 |
| Average True Range (ATR) | 0.87 | 0.13 |
| MACD | -0.19 | -0.03 |
| Stochastic Oscillator | 14.43 | 6.03 |
Price Performance
Historical ComparisonAbout CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.